These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30087012)

  • 21. Phosphate binders usage, patients knowledge, and adherence. A cross-sectional study in 4 centers at Qassim, Saudi Arabia.
    Aleidi AM; Alayed NJ; Alduraibi HM; Alqassimi NS; Ismail AA
    Saudi Med J; 2020 Oct; 41(10):1076-1082. PubMed ID: 33026048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health approach to addressing hyperphosphatemia among dialysis patients.
    Sehgal AR; Sullivan C; Leon JB; Bialostosky K
    J Ren Nutr; 2008 May; 18(3):256-61. PubMed ID: 18410881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using concordance with dosing techniques to achieve phosphate control.
    Koester LA; Rothstein M
    Nephrol News Issues; 2013 Nov; 27(12):22, 24, 26-8 passim. PubMed ID: 24354233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of educational interventions with dialysis patient].
    Parmier M; Gourieux B; Krummel T; Bazin-Kara D; Dory A; Hannedouche T
    Nephrol Ther; 2016 Dec; 12(7):516-524. PubMed ID: 27776970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate Kinetic Models in Hemodialysis: A Systematic Review.
    Laursen SH; Vestergaard P; Hejlesen OK
    Am J Kidney Dis; 2018 Jan; 71(1):75-90. PubMed ID: 29191624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
    Shigematsu T;
    Clin Nephrol; 2008 Nov; 70(5):404-10. PubMed ID: 19000540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions.
    Cernaro V; Calderone M; Gembillo G; Calabrese V; Casuscelli C; Lo Re C; Longhitano E; Santoro D
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphate control in end-stage renal disease: barriers and opportunities.
    Waheed AA; Pedraza F; Lenz O; Isakova T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2961-8. PubMed ID: 23901051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
    Cupisti A; D'Alessandro C; Baldi R; Barsotti G
    J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
    Dwyer JP; Sika M; Schulman G; Chang IJ; Anger M; Smith M; Kaplan M; Zeig S; Koury MJ; Blumenthal SS; Lewis JB;
    Am J Kidney Dis; 2013 May; 61(5):759-66. PubMed ID: 23369827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study.
    Leung S; McCormick B; Wagner J; Biyani M; Lavoie S; Imtiaz R; Zimmerman D
    BMC Nephrol; 2015 Dec; 16():205. PubMed ID: 26645271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of nicotinamide to treat hyperphosphatemia in dialysis patients.
    Lenglet A; Liabeuf S; Guffroy P; Fournier A; Brazier M; Massy ZA
    Drugs R D; 2013 Sep; 13(3):165-73. PubMed ID: 24000048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trial.
    Wileman V; Farrington K; Chilcot J; Norton S; Wellsted DM; Almond MK; Davenport A; Franklin G; Gane Mda S; Armitage CJ
    Ann Behav Med; 2014 Oct; 48(2):275-81. PubMed ID: 24532394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy evaluation of lanthanum carbonate for hyperphosphatemia in end-stage renal disease patients.
    Shigematsu T; Ohya M; Negi S; Masumoto AR; Nakashima YM; Iwatani Y; Moribata MK; Yamanaka S; Tatsuta K; Mima T
    Contrib Nephrol; 2015; 185():42-55. PubMed ID: 26023014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary glands: a new player in phosphorus metabolism.
    Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
    J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choosing not to take phosphate binders: the role of dialysis patients' medication beliefs.
    Wileman V; Chilcot J; Norton S; Hughes L; Wellsted D; Farrington K
    Nephron Clin Pract; 2011; 119(3):c205-13. PubMed ID: 21832846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis.
    Chen L; He JX; Chen YY; Ling YS; Lin CH; Guan TJ
    Ren Fail; 2018 Nov; 40(1):15-21. PubMed ID: 29295646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.